These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32510470)

  • 21. Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses.
    Kim KD; Hwang I; Ku KB; Lee S; Kim SJ; Kim C
    J Microbiol Biotechnol; 2020 Aug; 30(8):1109-1115. PubMed ID: 32627758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 and interferon blockade.
    Diamond B; Volpe BT; VanPatten S; Al Abed Y
    Mol Med; 2020 Nov; 26(1):103. PubMed ID: 33167852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately.
    Heininger U
    Pediatr Infect Dis J; 2020 Jul; 39(7):e123-e124. PubMed ID: 32427644
    [No Abstract]   [Full Text] [Related]  

  • 24. T cells found in coronavirus patients 'bode well' for long-term immunity.
    Leslie M
    Science; 2020 May; 368(6493):809-810. PubMed ID: 32439770
    [No Abstract]   [Full Text] [Related]  

  • 25. Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies.
    Market M; Angka L; Martel AB; Bastin D; Olanubi O; Tennakoon G; Boucher DM; Ng J; Ardolino M; Auer RC
    Front Immunol; 2020; 11():1512. PubMed ID: 32655581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Race to Develop a COVID-19 Vaccine.
    Am J Nurs; 2020 Oct; 120(10):14-15. PubMed ID: 32976132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should we continue covid-19 suppression measures based on a transmission model that ignored pre-existing human immunity?
    Spelsberg A; Keil U
    BMJ; 2020 Oct; 371():m3927. PubMed ID: 33051189
    [No Abstract]   [Full Text] [Related]  

  • 28. Progress and Concept for COVID-19 Vaccine Development.
    Wu SC
    Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
    [No Abstract]   [Full Text] [Related]  

  • 29. COVID-19 and the Path to Immunity.
    Stephens DS; McElrath MJ
    JAMA; 2020 Oct; 324(13):1279-1281. PubMed ID: 32915201
    [No Abstract]   [Full Text] [Related]  

  • 30. Next-generation vaccine platforms for COVID-19.
    van Riel D; de Wit E
    Nat Mater; 2020 Aug; 19(8):810-812. PubMed ID: 32704139
    [No Abstract]   [Full Text] [Related]  

  • 31. SARS-CoV-2 (Covid-19): Interferon-epsilon may be responsible of decreased mortality in females.
    Afsar CU; Afsar S
    J Reprod Immunol; 2020 Sep; 141():103154. PubMed ID: 32521376
    [No Abstract]   [Full Text] [Related]  

  • 32. Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends".
    Kleen TO; Galdon AA; MacDonald AS; Dalgleish AG
    Front Immunol; 2020; 11():2059. PubMed ID: 33013871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translating Science on COVID-19 to Improve Clinical Care and Support the Public Health Response.
    Del Rio C; Malani P
    JAMA; 2020 Jun; 323(24):2464-2465. PubMed ID: 32442244
    [No Abstract]   [Full Text] [Related]  

  • 34. Developing Covid-19 Vaccines at Pandemic Speed.
    Lurie N; Saville M; Hatchett R; Halton J
    N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
    [No Abstract]   [Full Text] [Related]  

  • 35. Targeting innate immunity by blocking CD14: Novel approach to control inflammation and organ dysfunction in COVID-19 illness.
    Martin TR; Wurfel MM; Zanoni I; Ulevitch R
    EBioMedicine; 2020 Jul; 57():102836. PubMed ID: 32574958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BCG-induced trained immunity: can it offer protection against COVID-19?
    O'Neill LAJ; Netea MG
    Nat Rev Immunol; 2020 Jun; 20(6):335-337. PubMed ID: 32393823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years.
    Saad-Roy CM; Wagner CE; Baker RE; Morris SE; Farrar J; Graham AL; Levin SA; Mina MJ; Metcalf CJE; Grenfell BT
    Science; 2020 Nov; 370(6518):811-818. PubMed ID: 32958581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Keeping track of the SARS-CoV-2 vaccine pipeline.
    Parker EPK; Shrotri M; Kampmann B
    Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 vaccine and boosted immunity: Nothing ad interim to do?
    Roncati L; Vadalà M; Corazzari V; Palmieri B
    Vaccine; 2020 Nov; 38(48):7581-7584. PubMed ID: 33071005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 in Africa: Dampening the storm?
    Mbow M; Lell B; Jochems SP; Cisse B; Mboup S; Dewals BG; Jaye A; Dieye A; Yazdanbakhsh M
    Science; 2020 Aug; 369(6504):624-626. PubMed ID: 32764055
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.